About the Company
We do not have any company description for Cyteir Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CYT News
Cyteir Therapeutics Inc CYTT
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq
Cyteir Therapeutics, Inc. (“Cyteir”) (Nasdaq: CYT) today announced that it has formally notified The Nasdaq Stock Market (“Nasdaq”) of its intent to delist ...
Cyteir Therapeutics executive buys $503k in company stock
Cyteir Therapeutics, Inc. (NASDAQ:CYT) has reported a significant purchase of its shares by a top executive, according to a recent filing with the Securities and Exchange Commission. Braden ...
Cyteir Therapeutics, Inc. (CYT) stock forecast and price target
Find the latest Cyteir Therapeutics, Inc. CYT analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Cyteir Therapeutics to delist from Nasdaq
LEXINGTON, Mass. - Cyteir Therapeutics, Inc. (NASDAQ:CYT), a biotechnology company, announced its decision to voluntarily delist its common stock from the Nasdaq Global Select Market. The company ...
ALGS Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases. Its drug ...
ANTX AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, which is in ...
Cyteir Therapeutics, Inc. (CYTT)
Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings ...
Cyteir Therapeutics, Inc. (CYTT)
Nasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC ...
Cyteir Therapeutics, Inc. (CYTT)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Loading the latest forecasts...